| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome | |
| | | Deletion (frameshift variant +2 more) | Hereditary cancer-predisposing syndrome | |
| | | Deletion (frameshift variant +2 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Deletion (frameshift variant) | Familial cancer of breast +1 more | |
| | | Single nucleotide variant (missense variant) | Cornelia de Lange syndrome 4 +1 more | |
| | | Single nucleotide variant (nonsense) | Adrenocortical carcinoma, hereditary +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice acceptor variant) | Juvenile myelomonocytic leukemia +4 more | |
| | | Duplication (frameshift variant) | Familial cancer of breast +4 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Deletion (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant) | NICE approved PARP inhibitor treatment +21 more | |
| | | Single nucleotide variant (nonsense +1 more) | Pancytopenia-developmental delay syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |